SpectraCure AB (publ)

Stockholm Stock Exchange SPEC.ST

SpectraCure AB (publ) Dividend Per Share for the year ending December 31, 2023: USD -0.00

SpectraCure AB (publ) Dividend Per Share is USD -0.00 for the year ending December 31, 2023, a 0.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

SpectraCure AB (publ) Dividend Per Share for the year ending December 31, 2022 was USD -0.00, a 0.00% change year over year.
SpectraCure AB (publ) Dividend Per Share for the year ending December 31, 2021 was USD -0.00, a 0.00% change year over year.
SpectraCure AB (publ) Dividend Per Share for the year ending December 31, 2020 was USD -0.00, a 0.00% change year over year.
SpectraCure AB (publ) Dividend Per Share for the year ending December 31, 2019 was USD -0.00, a 0.00% change year over year.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

Stockholm Stock Exchange: SPEC.ST

SpectraCure AB (publ)

CEO	Dr. Masoud Khayyami Ph.D.
IPO Date	July 1, 2015
Location	Sweden
Headquarters	Gasverksgatan 1
Employees	13
Sector	Healthcare
Industries Biotechnology 3D Printing Clinical Trials Pharmaceuticals Software & Operating Systems

Description

SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.

Key trends

Past 5 years